Literature DB >> 26325482

Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.

Bjorn Jensen1, Jeffrey Chen, Tim Furnish, Mark Wallace.   

Abstract

Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems. The route of delivery of cannabis is important as the bioavailability and metabolism are very different for smoking versus oral/sublingual routes. Gold standard clinical trials are limited; however, some studies have thus far shown evidence to support the use of cannabinoids for some cancer, neuropathic, spasticity, acute pain, and chronic pain conditions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26325482     DOI: 10.1007/s11916-015-0524-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  73 in total

Review 1.  Cannabis use and cancer.

Authors:  Wayne Hall; Donald MacPhee
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

2.  Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study.

Authors:  Igor Grant; Raul Gonzalez; Catherine L Carey; Loki Natarajan; Tanya Wolfson
Journal:  J Int Neuropsychol Soc       Date:  2003-07       Impact factor: 2.892

Review 3.  Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review.

Authors:  Jeanette M Tetrault; Kristina Crothers; Brent A Moore; Reena Mehra; John Concato; David A Fiellin
Journal:  Arch Intern Med       Date:  2007-02-12

Review 4.  Respiratory and immunologic consequences of marijuana smoking.

Authors:  Donald P Tashkin; Gayle C Baldwin; Theodore Sarafian; Steven Dubinett; Michael D Roth
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

Review 5.  Effects on the immune system.

Authors:  G A Cabral; A Staab
Journal:  Handb Exp Pharmacol       Date:  2005

6.  Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

Authors:  P J Little; D R Compton; M R Johnson; L S Melvin; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

7.  Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial.

Authors:  Jonathan S Berman; Catherine Symonds; Rolfe Birch
Journal:  Pain       Date:  2004-12       Impact factor: 6.961

8.  Effect of benzopyranoperidine, a delta-9-THC congener, on pain.

Authors:  P R Jochimsen; R L Lawton; K VerSteeg; R Noyes
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

9.  Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response.

Authors:  D Raft; J Gregg; J Ghia; L Harris
Journal:  Clin Pharmacol Ther       Date:  1977-01       Impact factor: 6.875

Review 10.  Cannabis and the brain.

Authors:  Leslie Iversen
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

View more
  32 in total

1.  Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.

Authors:  Zinah Zamil Al-Ghezi; Philip Brandon Busbee; Hasan Alghetaa; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Brain Behav Immun       Date:  2019-07-26       Impact factor: 7.217

Review 2.  Aging circadian rhythms and cannabinoids.

Authors:  Erik L Hodges; Nicole M Ashpole
Journal:  Neurobiol Aging       Date:  2019-03-25       Impact factor: 4.673

Review 3.  Cannabinoids in Pain Treatment: An Overview.

Authors:  Theresa Mallick-Searle; Barbara St Marie
Journal:  Pain Manag Nurs       Date:  2019-04       Impact factor: 1.929

4.  Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.

Authors:  G Michael Allan; Caitlin R Finley; Joey Ton; Danielle Perry; Jamil Ramji; Karyn Crawford; Adrienne J Lindblad; Christina Korownyk; Michael R Kolber
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

Review 5.  Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

Authors:  Suzanne Nielsen; Pamela Sabioni; Jose M Trigo; Mark A Ware; Brigid D Betz-Stablein; Bridin Murnion; Nicholas Lintzeris; Kok Eng Khor; Michael Farrell; Andrew Smith; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2017-03-22       Impact factor: 7.853

6.  Chronic pain patients' perspectives of medical cannabis.

Authors:  Brian J Piper; Monica L Beals; Alexander T Abess; Stephanie D Nichols; Maurice W Martin; Catherine M Cobb; Rebecca M DeKeuster
Journal:  Pain       Date:  2017-07       Impact factor: 6.961

7.  Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Authors:  Saphala Dhital; John V Stokes; Nogi Park; Keun Seok Seo; Barbara L F Kaplan
Journal:  Cell Immunol       Date:  2016-11-09       Impact factor: 4.868

Review 8.  Medical Cannabis for Neuropathic Pain.

Authors:  Gemayel Lee; Brittany Grovey; Tim Furnish; Mark Wallace
Journal:  Curr Pain Headache Rep       Date:  2018-02-01

Review 9.  Cannabis and Cannabinoids for Chronic Pain.

Authors:  E Alfonso Romero-Sandoval; Ashley L Kolano; P Abigail Alvarado-Vázquez
Journal:  Curr Rheumatol Rep       Date:  2017-10-05       Impact factor: 4.592

10.  Sleep deficits and cannabis use behaviors: an analysis of shared genetics using linkage disequilibrium score regression and polygenic risk prediction.

Authors:  Evan A Winiger; Jarrod M Ellingson; Claire L Morrison; Robin P Corley; Joëlle A Pasman; Tamara L Wall; Christian J Hopfer; John K Hewitt
Journal:  Sleep       Date:  2021-03-12       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.